All that you should know about the Company before applying for the IPO.
The public issue of equity shares of Rainbow Childrens Medicare Limited will open for subscription on April 27, 2022 and closes on April 29, 2022. It is expected to list on the stock exchanges on May 10, 2022. What does the company do? Why is the company going public? Who are its key competitors? Its key strengths, and lot more. Here’s everything that you want to know about the company to analyse the IPO.
Established in 1999 in Hyderabad (Telangana), the Company is a leading multi-specialty pediatric and obstetrics and gynecology hospital chain in India, operating 14 hospitals and 3 clinics in six cities, with a total bed capacity of 1,500 beds, as of December 31, 2021. It had the highest number of hospital beds amongst comparable players in the maternity and pediatric healthcare delivery sector, as of March 31, 2021 (a CRISIL Report). 5 of its hospitals are accredited by NABH and 3 of its hospitals are certified by EDGE.
Company’s core specialties are pediatrics, which includes newborn and pediatric intensive care, pediatric multi-specialty services, pediatric quaternary care (including multi organ transplants); and obstetrics and gynecology, which includes normal and complex obstetric care, multi-disciplinary fetal care, perinatal genetic and fertility care.
The Company follows a hub-and-spoke model in Hyderabad, Telangana with its Banjara Hills hospital being the hub and four spokes at four locations in Hyderabad (Secunderabad, LB Nagar, Kondapur and Hydernagar). It also has hub hospitals in Bengaluru, Chennai, Tamil Nadu and New Delhi-NCR. The Company follows a doctor engagement model whereby most of its core specialists work exclusively at its hospitals on a full-time retainer basis. As of December 31, 2021, the Company had 641 full-time doctors and 1,947 part time/visiting doctors.
Dr. Ramesh Kancharla, Dr. Dinesh Kumar Chirla & Dr. Adarsh Kancharla
Given below are the objectives of the Company –
The Company proposes to utilise the Net Proceeds from the Fresh Issue towards funding the following objects:
The Offer comprises a Fresh Issue by the company and an Offer for Sale by the selling shareholders. The company will not receive any proceeds from the Offer for Sale.
|IPO Size||₹ 1,580.85 Crore *|
|Offer Mix||Fresh Issue ₹ 280 Crore + Offer For Sale ₹ 1,300.85 Crore*|
|Price Band||₹ 516 - ₹ 542|
|Lot Size||27 Shares (& in multiples thereof)|
|Face Value||₹ 10|
|Application Amount||Min. ₹ 14,634 (1 lot) | Max. ₹ 1,90,242 (13 lots) [at upper price band]|
|Listing on||NSE & BSE|
|Registrar||KFin Technologies Limited|
|Discount||₹ 20 per equity share for Eligible Employees Category only|
|Cut-off time for UPI Mandate Confirmation||02-May-2022 (up to 12:00 PM)|
₹ 782.30 Crore
(50% of Net Issue Size)
₹ 234.69 Crore
(15% of Net Issue Size)
₹ 547.60 Crore
(35% of Net Issue Size)
|Employee Reservation Portion||
₹ 16.26 Crore
(3,00,000 Equity Shares)
|IPO Opens||April 27, 2022|
|IPO Closes||April 29, 2022|
|Finalization of the basis of allotment||May 05, 2022|
|Unblocking of funds / Initiation of refunds||May 06, 2022|
|Credit of equity shares to Demat accounts||May 09, 2022|
|Listing of equity shares||May 10, 2022|
Apply online in just 5 minutes!Apply Now Investment in securities market is subject to market risks, read all the related documents carefully before investing.